BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31741235)

  • 1. Heme as a target for protection against doxorubicin-induced apoptosis in H9c2 cardiomyocytes.
    Liu N; Zou L; Hu M; Zhang M
    Cell Stress Chaperones; 2019 Nov; 24(6):1211-1217. PubMed ID: 31741235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
    Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
    Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: role for heme oxygenase-1 down-modulation.
    Bernuzzi F; Recalcati S; Alberghini A; Cairo G
    Chem Biol Interact; 2009 Jan; 177(1):12-20. PubMed ID: 18845130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
    Upadhyay S; Mantha AK; Dhiman M
    J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling.
    Cheng X; Liu D; Xing R; Song H; Tian X; Yan C; Han Y
    Biomed Res Int; 2020; 2020():5923572. PubMed ID: 33134382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hesperetin Alleviates Doxorubicin-Induced Cytotoxicity in H9c2 Cells by Activating SIRT1/NRF2 Signaling].
    Li X; Yan A; Chang J; Li F; Zhu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):947-953. PubMed ID: 37866951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
    Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
    Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
    Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
    Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes.
    Han XZ; Gao S; Cheng YN; Sun YZ; Liu W; Tang LL; Ren DM
    Biosci Trends; 2012 Feb; 6(1):19-25. PubMed ID: 22426099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
    Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
    PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-induced cardiomyocyte apoptosis: Role of mitofusin 2.
    Tang H; Tao A; Song J; Liu Q; Wang H; Rui T
    Int J Biochem Cell Biol; 2017 Jul; 88():55-59. PubMed ID: 28483668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
    Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
    Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway.
    Zhang Y; Ahmad KA; Khan FU; Yan S; Ihsan AU; Ding Q
    Chem Biol Interact; 2019 May; 305():54-65. PubMed ID: 30928397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling.
    Ye M; Zhang L; Yan Y; Lin H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes.
    Shi R; Huang CC; Aronstam RS; Ercal N; Martin A; Huang YW
    BMC Pharmacol; 2009 Apr; 9():7. PubMed ID: 19368719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAY60-2770 attenuates doxorubicin-induced cardiotoxicity by decreased oxidative stress and enhanced autophagy.
    Zhao XX; Cho H; Lee S; Woo JS; Song MY; Cheng XW; Lee KH; Kim W
    Chem Biol Interact; 2020 Sep; 328():109190. PubMed ID: 32652078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
    Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
    Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress.
    Hu J; Wu Q; Wang Z; Hong J; Chen R; Li B; Hu Z; Hu X; Zhang M
    Biomed Pharmacother; 2019 Dec; 120():109475. PubMed ID: 31580970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
    Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
    Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.